Wockhardt has received US Food and Drug Administration (FDA) approval for marketing ceftriaxone sodium injection, a broad-spectrum new generation antibiotic, in the US market.

Siliconindia (http://www.siliconindia.com/shownewsdata.asp?newsno=31874&newscat=Business)